{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T22:58:39Z","timestamp":1780095519949,"version":"3.54.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T00:00:00Z","timestamp":1713916800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","lungcancerjournal.info","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.lungcan.2024.107802","type":"journal-article","created":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T15:29:51Z","timestamp":1713972591000},"page":"107802","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Combination of calretinin, MALAT1, and GAS5 as a potential prognostic biomarker to predict disease progression in surgically treated mesothelioma patients"],"prefix":"10.1016","volume":"192","author":[{"given":"Laura V.","family":"Klotz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swaantje","family":"Casjens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Johnen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5340-5584","authenticated-orcid":false,"given":"Dirk","family":"Taeger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Brik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1924-7404","authenticated-orcid":false,"given":"Florian","family":"Eichhorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"F\u00f6rster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Kaiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8141-0604","authenticated-orcid":false,"given":"Thomas","family":"Muley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christa","family":"Stolp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0221-2974","authenticated-orcid":false,"given":"Jan","family":"Gleichenhagen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Br\u00fcning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-5242-6942","authenticated-orcid":false,"given":"Hauke","family":"Winter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Eichhorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel G.","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lungcan.2024.107802_b0005","doi-asserted-by":"crossref","unstructured":"H. Sung, J. Ferlay, R.L. Siegel, M. Laversanne, I. Soerjomataram, A. Jemal, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a Cancer Journal for Clinicians. 2021;71(3):209-49.","DOI":"10.3322\/caac.21660"},{"issue":"135","key":"10.1016\/j.lungcan.2024.107802_b0010","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1183\/09059180.00007014","article-title":"Malignant pleural mesothelioma: history, controversy and future of a manmade epidemic","volume":"24","author":"Roe","year":"2015","journal-title":"Eur. Respir. Rev."},{"issue":"11","key":"10.1016\/j.lungcan.2024.107802_b0015","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.21037\/tlcr-22-199","article-title":"Multimodal therapy of epithelioid pleural mesothelioma: improved survival by changing the surgical treatment approach","volume":"11","author":"Klotz","year":"2022","journal-title":"Translational Lung Cancer Research."},{"issue":"10272","key":"10.1016\/j.lungcan.2024.107802_b0020","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0140-6736(20)32714-8","article-title":"First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised, open-label, phase 3 trial","volume":"397","author":"Baas","year":"2021","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.lungcan.2024.107802_b0025","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1186\/s12885-018-4113-3","article-title":"A prospective study to investigate the role of serial serum mesothelin in monitoring mesothelioma","volume":"18","author":"de Fonseka","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.lungcan.2024.107802_b0030","doi-asserted-by":"crossref","DOI":"10.1111\/1759-7714.15264","article-title":"Circulating SMRP and CA-125 before and after pleurectomy decortication for pleural mesothelioma","author":"Paajanen","year":"2024","journal-title":"Thorac Cancer"},{"key":"10.1016\/j.lungcan.2024.107802_b0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103577","article-title":"Personalising cancer medicine with prognostic markers","volume":"72","author":"Kerr","year":"2021","journal-title":"EBioMedicine"},{"key":"10.1016\/j.lungcan.2024.107802_b0040","doi-asserted-by":"crossref","unstructured":"R. Shah, L.V. Klotz, J. Glade. Current management and future perspective in pleural mesothelioma. Cancers (Basel). 2022;14(4).","DOI":"10.3390\/cancers14041044"},{"issue":"8","key":"10.1016\/j.lungcan.2024.107802_b0045","doi-asserted-by":"crossref","first-page":"643","DOI":"10.4155\/bio-2017-0009","article-title":"Recommendations for clinical biomarker specimen preservation and stability assessments","volume":"9","author":"Dakappagari","year":"2017","journal-title":"Bioanalysis"},{"key":"10.1016\/j.lungcan.2024.107802_b0050","doi-asserted-by":"crossref","first-page":"740","DOI":"10.3389\/fonc.2019.00740","article-title":"Liquid biopsy in malignant pleural mesothelioma: state of the art, pitfalls, and perspectives","volume":"9","author":"Cavallari","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.lungcan.2024.107802_b0055","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s40364-020-00194-4","article-title":"Circulating long non-coding RNA GAS5 (growth arrest-specific transcript 5) as a complement marker for the detection of malignant mesothelioma using liquid biopsies","volume":"8","author":"Weber","year":"2020","journal-title":"Biomarker Res."},{"issue":"4","key":"10.1016\/j.lungcan.2024.107802_b0060","doi-asserted-by":"crossref","first-page":"e18232","DOI":"10.1371\/journal.pone.0018232","article-title":"Association of MiR-126 with soluble mesothelin-related peptides, a marker for malignant mesothelioma","volume":"6","author":"Santarelli","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.lungcan.2024.107802_b0065","doi-asserted-by":"crossref","first-page":"9280170","DOI":"10.1155\/2017\/9280170","article-title":"Circulating miR-132-3p as a candidate diagnostic biomarker for malignant mesothelioma","volume":"2017","author":"Weber","year":"2017","journal-title":"Dis. Markers"},{"issue":"1","key":"10.1016\/j.lungcan.2024.107802_b0070","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1186\/1471-2407-10-242","article-title":"Development of an enzyme-linked immunosorbent assay for the detection of human calretinin in plasma and serum of mesothelioma patients","volume":"10","author":"Raiko","year":"2010","journal-title":"BMC Cancer"},{"issue":"9396","key":"10.1016\/j.lungcan.2024.107802_b0075","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1016\/S0140-6736(03)14794-0","article-title":"Mesothelin-family proteins and diagnosis of mesothelioma","volume":"362","author":"Robinson","year":"2003","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.lungcan.2024.107802_b0080","first-page":"453","article-title":"Survivin is highly expressed and promotes cell survival in malignant peritoneal mesothelioma","volume":"29","author":"Zaffaroni","year":"2007","journal-title":"Cell. Oncol."},{"issue":"1","key":"10.1016\/j.lungcan.2024.107802_b0085","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1515\/med-2021-0383","article-title":"MALAT1 promotes malignant pleural mesothelioma by sponging miR-141-3p","volume":"16","author":"Wang","year":"2021","journal-title":"Open Med (Wars)."},{"key":"10.1016\/j.lungcan.2024.107802_b0090","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.lungcan.2016.05.023","article-title":"Circulating epigenetic biomarkers in lung malignancies: from early diagnosis to therapy","volume":"107","author":"Tomasetti","year":"2017","journal-title":"Lung Cancer"},{"issue":"6","key":"10.1016\/j.lungcan.2024.107802_b0095","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00953-2019","article-title":"ERS\/ESTS\/EACTS\/ESTRO guidelines for the management of malignant pleural mesothelioma","volume":"55","author":"Scherpereel","year":"2020","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.lungcan.2024.107802_b0100","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.cca.2013.06.009","article-title":"Individualized correction of neuron-specific enolase (NSE) measurement in hemolyzed serum samples","volume":"424","author":"Tolan","year":"2013","journal-title":"Clinica Chimica Acta; International Journal of Clinical Chemistry."},{"issue":"1","key":"10.1016\/j.lungcan.2024.107802_b0105","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1093\/clinchem\/38.1.132","article-title":"Methods for measuring plasma hemoglobin in micromolar concentration compared","volume":"38","author":"Fairbanks","year":"1992","journal-title":"Clin. Chem."},{"issue":"6","key":"10.1016\/j.lungcan.2024.107802_b0110","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1515\/CCLM.2008.170","article-title":"Haemolysis: an overview of the leading cause of unsuitable specimens in clinical laboratories","volume":"46","author":"Lippi","year":"2008","journal-title":"Clin. Chem. Lab. Med."},{"issue":"4","key":"10.1016\/j.lungcan.2024.107802_b0115","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"issue":"6","key":"10.1016\/j.lungcan.2024.107802_b0120","doi-asserted-by":"crossref","first-page":"e0270535","DOI":"10.1371\/journal.pone.0270535","article-title":"Exploring solid-phase proximity ligation assay for survivin detection in urine","volume":"17","author":"Gleichenhagen","year":"2022","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.lungcan.2024.107802_b0125","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1007\/s11606-013-2755-z","article-title":"Six persistent research misconceptions","volume":"29","author":"Rothman","year":"2014","journal-title":"J. Gen. Intern. Med."},{"issue":"1","key":"10.1016\/j.lungcan.2024.107802_b0130","doi-asserted-by":"crossref","first-page":"14321","DOI":"10.1038\/s41598-018-32315-3","article-title":"Prediagnostic detection of mesothelioma by circulating calretinin and mesothelin - a case-control comparison nested into a prospective cohort of asbestos-exposed workers","volume":"8","author":"Johnen","year":"2018","journal-title":"Sci. Rep."},{"issue":"24","key":"10.1016\/j.lungcan.2024.107802_b0135","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15245896","article-title":"Tasks and experiences of the prospective, longitudinal, multicenter MoMar (Molecular Markers) Study for the early detection of mesothelioma in individuals formerly exposed to asbestos using liquid biopsies","volume":"15","author":"Weber","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"9","key":"10.1016\/j.lungcan.2024.107802_b0140","doi-asserted-by":"crossref","first-page":"e038892","DOI":"10.1136\/bmjopen-2020-038892","article-title":"Mesothelioma and radical surgery 2 (MARS 2): protocol for a multicentre randomised trial comparing (extended) pleurectomy decortication versus no (extended) pleurectomy decortication for patients with malignant pleural mesothelioma","volume":"10","author":"Lim","year":"2020","journal-title":"BMJ Open"},{"issue":"2","key":"10.1016\/j.lungcan.2024.107802_b0145","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S1470-2045(20)30606-9","article-title":"Surgery for malignant pleural mesothelioma after radiotherapy (SMART): final results from a single-centre, phase 2 trial","volume":"22","author":"Cho","year":"2021","journal-title":"Lancet Oncol."},{"issue":"11","key":"10.1016\/j.lungcan.2024.107802_b0150","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/j.jtho.2018.08.001","article-title":"Surgery in malignant pleural mesothelioma","volume":"13","author":"Bueno","year":"2018","journal-title":"J. Thorac. Oncol."},{"issue":"5","key":"10.1016\/j.lungcan.2024.107802_b0155","doi-asserted-by":"crossref","first-page":"593","DOI":"10.21037\/tlcr.2018.05.07","article-title":"A randomized phase II study of pleurectomy\/decortication preceded or followed by (neo-)adjuvant chemotherapy in patients with early stage malignant pleural mesothelioma (EORTC 1205)","volume":"7","author":"Raskin","year":"2018","journal-title":"Translational Lung Cancer Research."},{"issue":"11","key":"10.1016\/j.lungcan.2024.107802_b0160","doi-asserted-by":"crossref","first-page":"6712","DOI":"10.21037\/jtd-20-1910","article-title":"Three tumor markers for improved efficacy in the management of patients with malignant pleural mesothelioma","volume":"12","author":"Nakamura","year":"2020","journal-title":"J. Thorac. Dis."},{"issue":"5","key":"10.1016\/j.lungcan.2024.107802_b0165","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10051134","article-title":"Relapse patterns and tailored treatment strategies for malignant pleural mesothelioma recurrence after multimodality therapy","volume":"10","author":"Bellini","year":"2021","journal-title":"J. Clin. Med."},{"issue":"1","key":"10.1016\/j.lungcan.2024.107802_b0170","doi-asserted-by":"crossref","first-page":"89","DOI":"10.5858\/arpa.2017-0124-RA","article-title":"Guidelines for pathologic diagnosis of malignant mesothelioma 2017 update of the consensus statement from the international mesothelioma interest group","volume":"142","author":"Husain","year":"2018","journal-title":"Arch. Pathol. Lab. Med."},{"issue":"1","key":"10.1016\/j.lungcan.2024.107802_b0175","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3233\/CBM-220436","article-title":"Longitudinal monitoring of response to chemotherapy in patients with malignant pleural mesothelioma by biomarkers","volume":"38","author":"Bogar","year":"2023","journal-title":"Cancer Biomark."},{"issue":"21","key":"10.1016\/j.lungcan.2024.107802_b0180","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10214875","article-title":"Serum calretinin as a biomarker in malignant mesothelioma","volume":"10","author":"Zupanc","year":"2021","journal-title":"J. Clin. Med."},{"issue":"1","key":"10.1016\/j.lungcan.2024.107802_b0185","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25010190","article-title":"Serum calretinin and genetic variability as a prognostic and predictive factor in malignant mesothelioma","volume":"25","author":"Zupanc","year":"2023","journal-title":". Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.lungcan.2024.107802_b0190","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/s00432-023-05565-6","article-title":"BAP1, Wilms' tumor 1, and calretinin in predicting survival and response to first-line chemotherapy in patients with pleural mesothelioma","volume":"150","author":"Yuce","year":"2024","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"9","key":"10.1016\/j.lungcan.2024.107802_b0195","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1002\/ijc.32676","article-title":"Serum calretinin as an independent predictor for platinum resistance and prognosis in ovarian cancer","volume":"146","author":"Link","year":"2020","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.lungcan.2024.107802_b0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2023.104012","article-title":"LncRNAs and related molecular basis in malignant pleural mesothelioma: challenges and potential","volume":"186","author":"Xu","year":"2023","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"2","key":"10.1016\/j.lungcan.2024.107802_b0205","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ncrna.2022.02.004","article-title":"Long noncoding RNAs as promising biomarkers in cancer","volume":"7","author":"Beylerli","year":"2022","journal-title":"Noncoding RNA Res."},{"issue":"2","key":"10.1016\/j.lungcan.2024.107802_b0210","article-title":"Diagnostic, prognostic, and therapeutic significance of long non-coding RNA MALAT1 in cancer","volume":"1875","author":"Goyal","year":"2021","journal-title":"Biochim. Biophys. Acta"},{"issue":"12","key":"10.1016\/j.lungcan.2024.107802_b0215","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1038\/s41416-018-0320-6","article-title":"Loss of GAS5 tumour suppressor lncRNA: an independent molecular cancer biomarker for short-term relapse and progression in bladder cancer patients","volume":"119","author":"Avgeris","year":"2018","journal-title":"Br. J. Cancer"},{"issue":"2","key":"10.1016\/j.lungcan.2024.107802_b0220","article-title":"miR-625-3p and lncRNA GAS5 in liquid biopsies for predicting the outcome of malignant pleural mesothelioma patients treated with neo-adjuvant chemotherapy and surgery","volume":"5","author":"Kresoja-Rakic","year":"2019","journal-title":"Noncoding RNA"},{"issue":"10","key":"10.1016\/j.lungcan.2024.107802_b0225","doi-asserted-by":"crossref","first-page":"e0240321","DOI":"10.1371\/journal.pone.0240321","article-title":"Prognostic and clinicopathological significance of long noncoding RNA MALAT-1 expression in patients with non-small cell lung cancer: a meta-analysis","volume":"15","author":"Liu","year":"2020","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.lungcan.2024.107802_b0230","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s12943-018-0893-y","article-title":"Expression signatures of exosomal long non-coding RNAs in urine serve as novel non-invasive biomarkers for diagnosis and recurrence prediction of bladder cancer","volume":"17","author":"Zhan","year":"2018","journal-title":"Mol. Cancer"},{"issue":"3","key":"10.1016\/j.lungcan.2024.107802_b0235","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.lungcan.2015.11.002","article-title":"Non-coding RNA repertoires in malignant pleural mesothelioma","volume":"90","author":"Quinn","year":"2015","journal-title":"Lung Cancer"},{"issue":"11","key":"10.1016\/j.lungcan.2024.107802_b0240","doi-asserted-by":"crossref","first-page":"244","DOI":"10.21037\/atm.2017.06.60","article-title":"Diagnosis and prognosis-review of biomarkers for mesothelioma","volume":"5","author":"Sun","year":"2017","journal-title":"Annals of Translational Medicine."},{"issue":"50","key":"10.1016\/j.lungcan.2024.107802_b0245","doi-asserted-by":"crossref","first-page":"82700","DOI":"10.18632\/oncotarget.12408","article-title":"Circulating microRNAs found dysregulated in ex-exposed asbestos workers and pleural mesothelioma patients as potential new biomarkers","volume":"7","author":"Bononi","year":"2016","journal-title":"Oncotarget"}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500224003362?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500224003362?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T22:11:08Z","timestamp":1717539068000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500224003362"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":49,"alternative-id":["S0169500224003362"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2024.107802","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combination of calretinin, MALAT1, and GAS5 as a potential prognostic biomarker to predict disease progression in surgically treated mesothelioma patients","name":"articletitle","label":"Article Title"},{"value":"Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lungcan.2024.107802","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"107802"}}